Please login to the form below

Not currently logged in
Email:
Password:

Medicare

This page shows the latest Medicare news and features for those working in and with pharma, biotech and healthcare.

Pfizer, Sanofi and others set to increase US drug prices in 2021

Pfizer, Sanofi and others set to increase US drug prices in 2021

One key tenet of Biden’s drug pricing pledge is to allow Medicare to negotiate drug prices directly with pharma companies.

Latest news

More from news
Approximately 5 fully matching, plus 156 partially matching documents found.

Latest Intelligence

  • The US celebrates five years of biosimilars on the market – a look to the past, present and future The US celebrates five years of biosimilars on the market – a look to the past, present and future

    Between 2012 and 2016, annual spending on biologic drugs in the US nearly doubled, with unit prices accounting for 56% of the spending increase within Medicare Part D and 20% in ... In Medicare Part B, legislation could be passed to encourage physician

  • Eliminating pharmaceutical rebates, is this déjà vu? Eliminating pharmaceutical rebates, is this déjà vu?

    Due to consolidation in the industry, most prescription drug benefits, including Medicare Part D benefits, are administered by several significant PBMs. ... Completely eliminating Medicare Part D rebates within PBMs is not essential for lowering the

  • The global antibiotic crisis: a 2020 perspective The global antibiotic crisis: a 2020 perspective

    2020. It seeks to incentivise drug developers by changing the way Medicare reimburses hospitals for treating patients with bacterial infections.

  • Will biosimilars ever catch on in the US? Will biosimilars ever catch on in the US?

    Others call for more involvement from equally relevant and powerful government bodies, such as Congress, the Centers for Medicare and Medicaid Services, the US Patent and Trademark Office and the US

  • The Golden Goose The Golden Goose

    Yet another market-friendly idea that enjoys broad support among patient advocacy groups is allowing Medicare to negotiate with drugmakers. ... Unfortunately, on closer inspection, this pathway also presents difficulties. To negotiate effectively,

More from intelligence
Approximately 0 fully matching, plus 14 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Empowering Strategic Performance Ltd

OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic...

Latest intelligence

Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand
The Impetus InSite Platform® can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. Here, we share 10 of the most popular ways to...
Employee wellbeing in creative agencies: three tips to get you started
Paul Hutchings, founder of fox&cat, and new friend, Welfy, a workplace wellbeing training firm, discuss the importance of collaboration...
Managing unhelpful pressure in your creative agency: the human approach
Paul Hutchings, founder of fox&cat, answers the questions: what does it mean to be human in 2021? Are we putting ourselves under too much pressure?...